There is no single “best” sleeping pill for older adults, but the safest prescription options currently available are orexin receptor antagonists and very-low-dose doxepin. Both are FDA-approved for insomnia in seniors and carry significantly fewer risks than the medications most people reach for first. Before any medication, though, the recommended first-line treatment is a structured behavioral approach called Cognitive Behavioral Therapy for Insomnia (CBT-I), which outperforms sleep drugs in long-term outcomes for older adults.
The reason this question matters so much is that aging changes how the body processes sedating drugs. Fat-soluble medications like certain benzodiazepines can have half-lives of up to 96 hours in older patients, meaning a single dose can linger for days. That buildup is why so many common sleep aids cause next-day drowsiness, confusion, and falls in seniors that they wouldn’t cause in a 35-year-old.
Why Most Common Sleep Aids Are Risky for Seniors
The medications older adults are most likely to try first, whether over-the-counter antihistamines or a leftover prescription benzodiazepine, are the ones most likely to cause harm. The American Geriatrics Society maintains a list called the Beers Criteria, updated in 2023, which specifically flags these drug classes as potentially inappropriate for people 65 and older.
Over-the-counter antihistamines like diphenhydramine (Benadryl, ZzzQuil) and doxylamine (Unisom SleepTabs) are the most widely used sleep aids in the U.S., and they’re a poor choice for seniors. These drugs block a brain chemical called acetylcholine, which plays a key role in memory and coordination. In older adults, whose bodies clear these drugs more slowly, that blocking effect leads to confusion, memory impairment, dizziness, blurred vision, constipation, dry mouth, and urinary retention. Tolerance to the sleep-inducing effect also develops quickly, meaning they stop working while the side effects continue.
Benzodiazepines such as diazepam, lorazepam, and temazepam increase the risk of cognitive impairment, delirium, falls, and fractures in older adults. Some, like diazepam, have active byproducts that can accumulate in the body for days. Signs of toxicity may not even appear until weeks after someone starts taking them regularly. The Beers Criteria recommends avoiding all benzodiazepines in older adults for insomnia.
Zolpidem (Ambien), the most commonly prescribed sleep medication in the U.S., also poses serious problems. In a hospital-based study, patients taking zolpidem fell at a rate of 3.04 per 100 patients, compared to 0.71 per 100 among those not taking the drug. That’s more than four times the fall rate. For an older adult, a single fall can mean a hip fracture and months of lost independence.
Safest Prescription Options
Orexin Receptor Antagonists
These newer medications work differently from older sleep drugs. Instead of broadly sedating the brain, they block a specific wakefulness signal called orexin. This makes sleep feel more natural and causes fewer problems with balance, memory, and next-day grogginess.
Two are currently available: suvorexant (Belsomra) and lemborexant (Dayvigo). In a comparative study, lemborexant produced longer sleep on the first night of use (about 6 hours versus 5 hours for suvorexant). Suvorexant, however, had zero falls in the study group compared to a 5.3% fall rate with lemborexant, a difference that wasn’t statistically significant but may matter for someone already at high fall risk. Both drugs have been found to help prevent delirium, a common and dangerous condition in hospitalized older adults. For a senior who is unsteady on their feet, suvorexant may be the better starting choice. For someone whose main problem is simply not sleeping long enough, lemborexant may offer a faster improvement.
Very-Low-Dose Doxepin
Doxepin is an older antidepressant, but at extremely low doses (3 mg or 6 mg) it works purely as a sleep aid by blocking histamine receptors in the brain. The FDA approved these low doses for insomnia in both adults and seniors in 2010. In a four-week trial of older patients, 6 mg of doxepin significantly improved total sleep time and sleep quality compared to placebo, with benefits sustained throughout the trial. The recommended starting dose for adults over 65 is 3 mg once daily, with an increase to 6 mg if needed. At these doses, the drug doesn’t produce the side effects associated with higher antidepressant doses.
Low-Dose Trazodone
Trazodone is an antidepressant frequently prescribed off-label for sleep at low doses (25 to 100 mg). Evidence supports its effectiveness for both primary insomnia and insomnia related to other conditions, including depression and dementia. It’s generally considered safe at these low doses, though it can cause dizziness and low blood pressure upon standing, which is a concern for fall-prone seniors. It’s not FDA-approved specifically for insomnia, so it’s typically used when the approved options aren’t a good fit.
Melatonin: A Reasonable Starting Point
Melatonin is available without a prescription and is one of the safer options for older adults, though the evidence for its effectiveness is modest. If you want to try it, experts recommend doses between 0.3 mg and 2 mg taken one hour before bedtime. Most large studies in older adults used a 2 mg dose. Higher doses (5 mg, 10 mg) are commonly sold but aren’t more effective and can cause next-day drowsiness.
A prescription melatonin receptor agonist called ramelteon (Rozerem) is also available. The American Academy of Sleep Medicine suggests it for sleep-onset insomnia, noting that it reduces the time to fall asleep by about 10 minutes on average compared to placebo. That’s a modest benefit, but it comes with essentially no concerning side effects, making it a reasonable option for someone who mainly struggles with falling asleep rather than staying asleep.
CBT-I: The First-Line Treatment Most People Skip
Cognitive Behavioral Therapy for Insomnia is a structured program, typically lasting four to eight weeks, that retrains your sleep habits and addresses the anxious thought patterns that keep you awake. It’s recommended as the first treatment for insomnia in older adults by every major sleep medicine organization, ahead of any medication.
The reason is simple: it works better in the long run. In a randomized trial of older adults, those who completed a digital CBT-I program were two to three times more likely to experience meaningful improvement and full remission of insomnia at the 12-month mark compared to those who received general sleep education. Participants gained 24 to 46 minutes of total sleep time on average, with the quality and restfulness of that sleep also improving. Unlike medications, the benefits don’t disappear when you stop. The skills you learn continue working.
CBT-I is now available through apps and online programs, making it accessible even for people who can’t easily get to a therapist’s office. It involves techniques like sleep restriction (spending less time in bed but making that time more efficient), stimulus control (using the bed only for sleep), and relaxation training.
Check Whether Another Medication Is the Problem
Before adding a sleep medication, it’s worth asking whether an existing prescription is causing the insomnia. A large Irish database study found that 2.5% of older adults prescribed an SSRI or SNRI antidepressant were subsequently prescribed a sleep medication, a pattern researchers identified as a likely prescribing cascade. In other words, the antidepressant was causing the insomnia, and instead of adjusting it, a second drug was added on top. Common culprits beyond antidepressants include certain blood pressure medications, steroids, and stimulating asthma drugs. If your insomnia started or worsened after beginning a new medication, that connection is worth raising with your prescriber before starting a sleep aid.